Blink Health Announces Former U.S. Senator Kelly Ayotte Will Join Board of Directors
Blink Health, the app that makes prescription drugs affordable for everyone, announces that former U.S. Senator and New Hampshire Attorney General Kelly Ayotte will join its board of directors.
A senior advisor to Blink since 2017, Ayotte will take an even more active role supporting the company’s mission of bringing transparency and affordability to the prescription drug industry. Ayotte’s public policy expertise will be invaluable as the company revolutionizes the opaque pharmaceutical supply chain, dominated by middlemen known as Pharmacy Benefit Managers (PBMs). Blink’s e-commerce service bypasses the PBMs to provide customers access to affordable prescription drug prices.
A proven bipartisan leader, Ayotte will be a strong advocate for Blink’s important mission of increasing accessibility and reducing prescription drug costs for American families. She will work with the company’s other experienced board members – including Executive Chairman Bill Doyle, co-founders Geoffrey and Matthew Chaiken and Tom Tryforos – to support Blink’s continued growth and help expand the company’s efforts to provide the lowest prices on prescription medications.
“Kelly understands that Blink threatens industry incumbents who have tried to protect their profits by keeping drug prices high,” said Geoffrey Chaiken, CEO of Blink Health. “We’re honored to have her join us and confident we will benefit from her expertise and insights.”
“I’ve always been a fierce advocate for improving the U.S. healthcare system and lowering patient costs, so I was drawn to Blink as a new private market solution to the drug price crisis,” said Kelly Ayotte. “Blink brings transparency and a patient-centric approach to the prescription supply chain providing policy makers with an effective model for needed change.”
Ayotte has been a supporter of bringing safety to the pharmaceutical industry, including banning the use of anonymous PBM cash discount cards and requiring digital ID verification for controlled substances. As a Senator, she was a lead cosponsor of the Comprehensive Addiction and Recovery Act, federal legislation to tackle the heroin and prescription opioid abuse epidemic in the U.S.
Blink Health customers can save up to 80% on generic prescription medications compared to estimated retail prices. The company also recently announced free home delivery which allows customers to now choose between picking up their prescriptions at a local pharmacy or having them delivered directly to their door.
Blink’s more than 34,000 retail pharmacy partners include Walmart, Costco, most major grocery chains and thousands of independent pharmacies around the country, representing more retail locations than the nation's McDonald’s, Starbucks and KFC locations combined. Blink is available to anyone with no vouchers, coupons or membership fees and does not use cash discount cards.
About Blink Health
Blink Health is the app for inexpensive prescription drug prices. Users get the exact same medications at much lower prices by purchasing on Blink’s website or app and either picking up their prescriptions at local pharmacies or getting their medications delivered to their home. As the first e-commerce service of its kind, Blink Health negotiates directly with prescription medication suppliers on behalf of all Americans and uses technology to bypass powerful intermediaries. Founded in 2014, more than half a million people have purchased their prescription drugs through Blink.
Any savings claims herein are based on a comparison between Blink prices and generic drug retail prices for an individual without prescription drug coverage. Blink Health is not insurance. Please go to blinkhealth.com for state by state availability and for terms and conditions of the Price Match Guarantee. The discounted drug prescription provider is Blink Health Administration, LLC, 233 Spring Street, 8th Floor East, NY NY 10013. 1(855) 979-8290.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181113005718/en/